Fibrinogen, blood viscosity, and cerebral ischemia.
- 1 March 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 16 (2), 192-198
- https://doi.org/10.1161/01.str.16.2.192
Abstract
This study examines the effect of fibrinogen and consequent blood viscosity reduction on cerebral blood flow and cellular injury following severe cerebral ischemia for 30 minutes in 78 Wistar rats. In half of these rats 10 to 15 cc's of blood was removed and replaced with a mixture of 5% albumin and autologous red blood cells maintaining a constant hematocrit but resulting in a 30% decrease in fibrinogen and corresponding reduction in viscosity. Fibrinogen reduction in a slight increase in baseline CBF and the elimination of post-ischemic hyperemia at 24 hours. Both study and control animals showed a similar decrease in CBF at 30 minutes and 2 hours. There was no significant difference in the severity of ischemic cellular change between the fibrinogen reduction group and controls, although there was a significant inverse relationship between the amount of viscosity change and severity of cellular injury within the treatment group. Fibrinogen reduction alone cannot significantly ameliorate ischemic injury in this model. Viscosity reduction therapy should include reduction of hematocrit and alteration of red cell deformability.This publication has 19 references indexed in Scilit:
- Controlled Trial of Ancrod in Ischemic StrokeArchives of Neurology, 1983
- Regional cerebral blood flow and glucose metabolism following transient forebrain ischemiaAnnals of Neurology, 1982
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982
- The Role of Adenosine in the Regulation of Cerebral Blood FlowJournal of Cerebral Blood Flow & Metabolism, 1981
- Noninvasive Tomographic Study of Cerebral Blood Flow and Oxygen Metabolism in vivoEuropean Neurology, 1981
- EFFECT OF HÆMATOCRIT ON CEREBRAL BLOOD-FLOW IN MANThe Lancet, 1977
- The Effect of Clofibrate on Glucose Tolerance, Insulin Secretion, Triglycerides and Fibrinogen in Patients with Coronary Heart DiseaseActa Medica Scandinavica, 1977
- Behandlung der akuten zerebralen Mangeldurchblutung mit niedermolekularem DextranDeutsche Medizinische Wochenschrift (1946), 1976
- Anoxic-ischaemic cell change in rat brain light microscopic and fine-structural observationsJournal of the Neurological Sciences, 1972
- Experimental Cerebral Infarction: Modification by Treatment with Hemodiluting, Hemoconcentrating, and Dehydrating AgentsJournal of Neurosurgery, 1967